DUBLIN--(BUSINESS WIRE)--The "Analyzing Generics Market in Canada 2017" report has been added to Research and Markets' offering.
The Canadian generics market was worth over USD 4 billion in 2016 and is not expected to post significant growth in the coming years. In fact, the market is expected to barely cross a value of USD 5 billion by the end of 2021.
Analyzing Generics Market in Canada 2017 - a comprehensive coverage of the Canadian generic drugs market. Beginning with a sectional description on the global generic industry, the report looks at an overview of the industry, an analysis of the market volume and value, industry segmentation and an industry forecast.
The Generics Industry in Canada is analyzed through an industry overview which spans the data from 2012 till 2021. An analysis of the industry's value and volume data is included along with an industry segmentation by geography. Industry forecast of the industry is also included.
Analysis of the major industry players in the Canadian generics market are analyzed through an analysis of their business segments, a financial analysis and a SWOT analysis. Players analyzed include Mylan, Lupin Pharma Canada, Sanofi, Teva and others. This concludes this comprehensive research report Research.
Key Topics Covered:
A. Executive Summary
B. Analyzing the Global Generics Industry
C. Generics Industry in Canada
D. Generics Industry in Canada: Porter's Five Forces Strategy Analysis
E. Major Industry Players
F. Glossary of Terms
Companies Mentioned
- Allergan Plc
- Apotex Inc.
- Lupin Limited
- Mylan N.V.
- Sandoz International GmbH
- Sanofi SA
- Teva Pharmaceutical Industries Limited
For more information about this report visit https://www.researchandmarkets.com/research/x6pqtc/analyzing
